Assessment of new technologies for cervical cancer screening.
Villa
Luisa Lina
LL
D052685:Alphapapillomavirus / Q000302:isolation & purification*; D014408:Biomarkers, Tumor / Q000302:isolation & purification*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics / Q000378:metabolism*; D004279:DNA, Viral / Q000302:isolation & purification; D055088:Early Detection of Cancer; D005260:Female; D005786:Gene Expression Regulation; D019942:Genes, p16; D005819:Genetic Markers; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*
D014408:Biomarkers, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16; D004279:DNA, Viral; D005819:Genetic Markers